The Biden administration proposed expanding coverage of weight loss medication to Medicaid and Medicare recipients. RFK Jr.
Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $35 ...
The Federal Drug Administration (FDA) is warning consumers about unapproved semaglutide, a popular weight loss drug associated with the brand names Ozempic and Wegovy.
Popular weight-loss drugs like Wegovy or Ozempic would be covered by Medicare or Medicaid under a newly-proposed rule by the ...
The Biden administration plans to require Medicare and Medicaid to offer coverage of weight loss medications for people seeking obesity treatment.The new rule, which was proposed by the administration ...
Millions of Americans with obesity would be eligible to have popular weight-loss drugs like Wegovy or Zepbound covered by ...